Theracim

Theracim

Basic Prescribing Info
Contents
Each 10 mL Nimotuzumab 50 mg, dibasic Na phosphate 18 mg, monobasic Na phosphate 4.5 mg, NaCl 86 mg, polysorbate 80 2 mg, water for inj 10 mL
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FE - EGFR (Epidermal Growth Factor Receptor) inhibitors ; Used in the treatment of cancer.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in